A decade of Alzheimer’s Research & Therapy: reflections on the past, present, and future per Douglas Galasko, Philip Scheltens

Obtenir text complet

Low testosterone levels relate to poorer cognitive function in women in an APOE-ε4-dependant manner per Melanie A. Dratva, Sarah J. Banks, Matthew S. Panizzon, Douglas Galasko, Erin E. Sundermann, for the Alzheimer’s Disease Neuroimaging Initiative

Obtenir text complet

Small RNA Changes in Plasma Have Potential for Early Diagnosis of Alzheimer’s Disease before Symptom Onset per Joanna Palade, Eric Alsop, Amanda Courtright-Lim, Michael Hsieh, Timothy G. Whitsett, Douglas Galasko, Kendall Van Keuren-Jensen

Obtenir text complet

Sex differences in Alzheimer’s-related Tau biomarkers and a mediating effect of testosterone per Erin E. Sundermann, Matthew S. Panizzon, Xu Chen, Murray Andrews, Douglas Galasko, Sarah J. Banks, for the Alzheimer’s Disease Neuroimaging Initiative

Obtenir text complet

Arterial stiffening acts synergistically with APOE genotype and AD biomarker status to influence memory in older adults without dementia per Katherine J. Bangen, Denis S. Smirnov, Lisa Delano-Wood, Christina E. Wierenga, Mark W. Bondi, David P. Salmon, Douglas Galasko

Obtenir text complet

Effects of baseline CSF α-synuclein on regional brain atrophy rates in healthy elders, mild cognitive impairment and Alzheimer's disease. per Niklas Mattsson, Philip Insel, Duygu Tosun, Jing Zhang, Clifford R Jack, Douglas Galasko, Michael Weiner, Alzheimer’s Disease Neuroimaging Initiative

Obtenir text complet

Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathy. per Leslie Crews, Brian Spencer, Paula Desplats, Christina Patrick, Amy Paulino, Edward Rockenstein, Lawrence Hansen, Anthony Adame, Douglas Galasko, Eliezer Masliah

Obtenir text complet

Prediction of conversion from mild cognitive impairment to dementia with neuronally derived blood exosome protein profile per Charisse N. Winston, Edward J. Goetzl, Johnny C. Akers, Bob S. Carter, Edward M. Rockenstein, Douglas Galasko, Eliezer Masliah, Robert A. Rissman

Obtenir text complet

Sex differences in Alzheimer’s disease: plasma MMP-9 and markers of disease severity per Amaryllis A. Tsiknia, Erin E. Sundermann, Emilie T. Reas, Steven D. Edland, James B. Brewer, Douglas Galasko, Sarah J. Banks, for the Alzheimer’s Disease Neuroimaging Initiative

Obtenir text complet

NT1-Tau Is Increased in CSF and Plasma of CJD Patients, and Correlates with Disease Progression per David Mengel, Tze How Mok, Akin Nihat, Wen Liu, Robert A. Rissman, Douglas Galasko, Henrik Zetterberg, Simon Mead, John Collinge, Dominic M. Walsh

Obtenir text complet

Community memory screening as a strategy for recruiting older adults into Alzheimer’s disease research per Guerry M. Peavy, Cecily W. Jenkins, Emily A. Little, Christina Gigliotti, Amanda Calcetas, Steven D. Edland, James B. Brewer, Douglas Galasko, David P. Salmon

Obtenir text complet

Rapid and ultra-sensitive quantitation of disease-associated α-synuclein seeds in brain and cerebrospinal fluid by αSyn RT-QuIC per Bradley R. Groveman, Christina D. Orrù, Andrew G. Hughson, Lynne D. Raymond, Gianluigi Zanusso, Bernardino Ghetti, Katrina J. Campbell, Jiri Safar, Douglas Galasko, Byron Caughey

Obtenir text complet

Practical use of DAT SPECT imaging in diagnosing dementia with Lewy bodies: a US perspective of current guidelines and future directions per Deirdre M. O’Shea, Alexander Arkhipenko, Douglas Galasko, Jennifer G. Goldman, Jennifer G. Goldman, Zulfiqar Haider Sheikh, George Petrides, Jon B. Toledo, James E. Galvin

Obtenir text complet

Correction to: Rapid and ultra-sensitive quantitation of disease-associated α-synuclein seeds in brain and cerebrospinal fluid by αSyn RT-QuIC per Bradley R. Groveman, Christina D. Orrù, Andrew G. Hughson, Lynne D. Raymond, Gianluigi Zanusso, Bernardino Ghetti, Katrina J. Campbell, Jiri Safar, Douglas Galasko, Byron Caughey

Obtenir text complet

Alzheimer’s Disease Pathology in Middle Aged and Older People with HIV: Comparisons with Non-HIV Controls on a Healthy Aging and Alzheimer’s Disease Trajectory and Relationships wi... per Erin E. Sundermann, Laura M. Campbell, Olivia Villers, Mark W. Bondi, Ben Gouaux, David P. Salmon, Douglas Galasko, Virawudh Soontornniyomkij, Ronald J. Ellis, David J. Moore

Obtenir text complet

Performance of αSynuclein RT-QuIC in relation to neuropathological staging of Lewy body disease per Sara Hall, Christina D. Orrù, Geidy E. Serrano, Douglas Galasko, Andrew G. Hughson, Bradley R. Groveman, Charles H. Adler, Thomas G. Beach, Byron Caughey, Oskar Hansson

Obtenir text complet

Biomarkers of neurodegeneration and glial activation validated in Alzheimer's disease assessed in longitudinal cerebrospinal fluid samples of Parkinson's disease. per Michael Bartl, Mohammed Dakna, Douglas Galasko, Samantha J Hutten, Tatiana Foroud, Marian Quan, Kenneth Marek, Andrew Siderowf, Jonas Franz, Claudia Trenkwalder, Brit Mollenhauer, Parkinson’s Progression Markers Initiative

Obtenir text complet

Listening session with the US Food and Drug Administration, Lewy Body Dementia Association, and an expert panel per Marwan N. Sabbagh, Angela Taylor, Douglas Galasko, James E. Galvin, Jennifer G. Goldman, James B. Leverenz, Kathleen L. Poston, Bradley F. Boeve, David J. Irwin, Joseph F. Quinn

Obtenir text complet

Microstructural brain changes track cognitive decline in mild cognitive impairment per Emilie T. Reas, Donald J. Hagler, Jr, Nathan S. White, Joshua M. Kuperman, Hauke Bartsch, Christina E. Wierenga, Douglas Galasko, James B. Brewer, Anders M. Dale, Linda K. McEvoy

Obtenir text complet

A rapid α‐synuclein seed assay of Parkinson’s disease CSF panel shows high diagnostic accuracy per Christina D. Orrù, Thong C. Ma, Andrew G. Hughson, Bradley R. Groveman, Ankit Srivastava, Douglas Galasko, Rachel Angers, Patrick Downey, Karen Crawford, Samantha J. Hutten, Un Jung Kang, Byron Caughey

Obtenir text complet